Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03360825 · ClinicalTrials.gov registry record

Electrophysiological Comparison of mAP and mADM Using EMG

A clinical trial of Surgery, sponsored by Mayo Clinic.

Completed
Registry status
56
Enrollment target
1
Study location

NCT03360825: Completed study of Surgery, sponsored by Mayo Clinic.

NCT03360825 is a study of Surgery that has completed, run by Mayo Clinic. The registered enrollment target is 56 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03360825, a study of Surgery, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
56 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this clinical investigation is to examine a prototype of a quantitative monitoring instrument that will meet most, if not all, of the clinical requirements.

Primary Outcome

Agreement between the mAP and mADM EMG based TOF ratios

Conditions Studied

Interventions

  • DEVICE TetraGraph

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2017-11-20
Est. Completion 2018-03-20
Mayo Clinic

2,844 total trials

What the finished NCT03360825 record still lists

NCT03360825 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which TetraGraph is the first listed.

NCT03360825 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03360825 about?

NCT03360825 is a clinical study titled "Electrophysiological Comparison of mAP and mADM Using EMG". The primary aim of this clinical investigation is to examine a prototype of a quantitative monitoring instrument that will meet most, if not all, of the clinical requirements.

What is the current status of trial NCT03360825?

This trial is currently completed. The enrollment target is 56 participants. The study started on 2017-11-20. Estimated completion is 2018-03-20.

What conditions does trial NCT03360825 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT03360825?

The interventions under investigation include: TetraGraph (DEVICE).

Who is sponsoring clinical trial NCT03360825?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03360825 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03360825's enrollment target sits among peer trials

56 86th of 120 higher than 34 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03360825, the US trial registry maintained by the National Library of Medicine. NCT03360825 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.